Insiders who reported open-market trades in the last 12 months at the companies Medina Manuel Hidalgo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
Terilyn J. Monroe - $14.82M in GH purchases and sales in the last 12 months
Chris Freeman - $13.68M in GH purchases and sales in the last 12 months
Helmy Eltoukhy - $12.63M in GH purchases and sales in the last 12 months
Kumud Kalia - $5.78M in GH purchases and sales in the last 12 months
John G. Saia - $4.25M in GH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Medina Manuel Hidalgo is a corporate insider, tracked as Director of Guardant Health, Inc. (GH). InsiderAlpha holds 21 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Medina Manuel Hidalgo submitted recently?
4 primary Form 4 filings in the last 90 days, covering 1 company.
Has Medina Manuel Hidalgo been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($922K) across all tracked filings.
Medina Manuel Hidalgo is Director of Guardant Health, Inc. (GH). 21 SEC Form 4 filings on record going back to 2025, most recently on 21 September 2026. Most recent open-market trade: sold $123K of GH on 6 August 2026. Lifetime open-market sales: $922K.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Medina Manuel Hidalgo.
InsiderAlpha's records for Medina Manuel Hidalgo go back to 2025: 21 primary Form 4 filings, an average of 10.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
